Steven Artandi, MD, PhD

@SCIDirector

Stanford University medical oncologist and cancer biologist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.

Joined November 2018

Tweets

You blocked @SCIDirector

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @SCIDirector

  1. 17 hours ago

    Bass Center recently opened a new inpatient unit featuring hematology, oncology, and stem cell transplant services, with expanded surgery, imaging, and diagnostic capacities.

    Undo
  2. Dec 10

    SCI member Crystal Mackall and colleagues modified to remain active in mice even under conditions that would normally result in their exhaustion - important implications for developing the next generation of treatments.

    Undo
  3. Dec 9

    Don't forget to check out SCI member Russ Altman at the Presidential Symposium on Tuesday 12/10: Role of Pharmacogenomics, Computational Biology, and Other "Omics" Approaches in Precision Medicine and Regulatory Science

    Undo
  4. Dec 8

    SCI member Lori Muffly will speak at on Monday 12/9 morning and afternoon: Acute Lymphoblastic Leukemia: Pediatric-inspired Protocols in Adult ALL: Are the Results Bearing Fruit?

    Undo
  5. Dec 5

    In a recent episode of "The Future of Everything," host Russ Altman and guest Ross Shachter discussed the role of in improving malignant tumor detection accuracy.

    Undo
  6. Dec 6

    Highly recommended session for trainees! SCI member Ami Bhatt will present at Sunday's Special Interest Session: TRTH Symposium: A Decade of Training the Future Leaders in Translational Research, 4:30-6:30 PM in W314.

    Undo
  7. Dec 5

    Don't miss SCI leader on Friday 12/6 at : Liquid Biopsies As Integrated Biomarkers in Pediatric and Adult Hematologic Malignancies, 3:55-4:45 PM in W222.

    Undo
  8. Dec 4

    is almost here! I'll be sharing recommendations for exciting talks by SCI members. First up, Ravi Majeti's talk at Friday's Scientific Workshops: Modeling RUNX1-FPD/Acute Myeloid Leukemia Mutations in Primary Human Hematopoietic Stem Cells.

    Undo
  9. Dec 3

    SCI member James Brooks discusses the risks and benefits of PSA testing, and clarifies some misconceptions about screening.

    Undo
  10. Dec 2

    SCI leader Sam Gambhir is leading the way in finding innovative ways to detect cancer early. Join us in raising awareness for the potentially lifesaving benefits of cancer screening. Learn more at

    Undo
  11. Nov 28

    This , I am thankful for our amazing clinicians, researchers, staff, students, and patients who inspire me each and every day. It is an honor to be part of our SCI community!

    Undo
  12. Nov 27

    SCI member Ranjana Advani and colleagues explore the prognostic significance of MYC rearrangement and translocation partner in diffuse large b-cell , and discuss diagnostic and therapeutic implications for certain patients.

    Undo
  13. Nov 26

    SCI member Youn Kim and colleagues found in a phase II trial that pembrolizumab demonstrated significant antitumor activity, with durable responses and a favorable safety profile, in patients with advanced and .

    Undo
  14. Nov 25

    SCI members Jim Ford and Michael Snyder used deep bisulfite sequencing to find that DNA methylation may play a broader role in early-onset familial .

    Undo
  15. Nov 23

    Second half under way!

    Undo
  16. Nov 23

    Tied at 10 in the Big Game midway through second quarter go !

    Undo
  17. Nov 22

    . and researchers identified unique characteristics of VISTA, an immune checkpoint protein that inhibits T cell response against . Their insights could guide future development of drugs that target these proteins.

    Undo
  18. Nov 21

    Congratulations to Hongjie Dai, Julie Parsonnet and Joseph Wu on being elected to the National Academy of Medicine! Proud to have you as members of the Cancer Institute.

    Undo
  19. Nov 20

    Excited to share our work on searching for therapeutic strategies for diffuse midline gliomas, that also uncovered metabolic vulnerabilities in this fatal childhood brain tumor.

    Show this thread
    Undo
  20. Nov 20

    SCI members Crystal Mackall and Robbie Majzner discuss major factors affecting the efficacy of therapy, lessons learned from clinical trials, and future directions for research.

    Undo

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·